2019 年第一季度报告 公司代码：603360 公司简称：百傲化学 大连百傲化学股份有限公司 2019 年第一季度报告 1 / 19 | 一、 | 重要提示 3 | | --- | --- | | 二、 | 公司基本情况 3 | | 三、 | 重要事项 6 | | 四、 | 附录 8 | 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 二、 公司基本情况 2.1 主要财务数据 单位：元 币种：人民币 | | 本报告期末 | 上年度末 | 本报告期末比上年度末增 | | | --- | --- | --- | --- | --- | | | | | 减(%) | | | 总资产 | 985,072,287.93 | 897,381,513.43 | | 9.77 | | 归属于上市公司 | 831,296,255.63 | 799,343,117.50 | | 4.00 | | 股东的净资产 | | | | | | | 年初至报告期末 | 上年初至上年报 ...

2018 年第三季度报告 公司代码：603360 公司简称：百傲化学 大连百傲化学股份有限公司 2018 年第三季度报告 | 目录 | | --- | | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 6 | | 四、 | 附录 | 9 | 2018 年第三季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人刘宪武、主管会计工作负责人王希梁及会计机构负责人（会计主管人员）刘东光 保证季度报告中财务报表的真实、准确、完整。 1.4 本公司第三季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 单位：元 币种：人民币 本报告期末 上年度末 本报告期末比上年度末 增减(%) 总资产 936,043,455.24 779,330,217.36 20.11% 归属于上市公司 股东的净资产 762,742,913.41 68 ...

Financial Performance - The company's operating revenue for the first half of 2018 was ¥252,056,841.71, representing a 31.96% increase compared to ¥191,015,251.35 in the same period last year[16]. - The net profit attributable to shareholders for the first half of 2018 was ¥63,086,840.98, up 15.53% from ¥54,607,121.92 in the previous year[16]. - The net cash flow from operating activities increased by 30.01%, reaching ¥73,447,130.06 compared to ¥56,492,478.96 in the same period last year[16]. - The company reported a net profit after deducting non-recurring gains and losses of ¥61,207,392.73, which is an 18.92% increase from ¥51,467,381.41 in the previous year[16]. - Basic earnings per share for the first half of 2018 were ¥0.34, a 17.24% increase from ¥0.29 in the same period last year[17]. - The company achieved a revenue of CNY 252.06 million, representing a year-on-year growth of 31.96%[34]. - The net profit attributable to shareholders was CNY 63.09 million, an increase of 15.53% compared to the previous year[29]. - The company reported a total profit for the current period of ¥75,995,151.83, compared to ¥64,399,800.51 in the previous period, marking an 18.5% increase[99]. - The company’s total comprehensive income for the current period was ¥62,931,421.39, compared to ¥54,592,620.93 in the previous period, reflecting an increase of 15.5%[99]. Assets and Liabilities - The company's total assets as of the end of the reporting period were ¥849,692,618.89, a 9.03% increase from ¥779,330,217.36 at the end of the previous year[16]. - Total liabilities amounted to CNY 100,339,712.58, up from CNY 92,908,732.45, which is an increase of around 8.5%[93]. - Owner's equity reached CNY 749,352,906.31, compared to CNY 686,421,484.91, showing a growth of about 9.2%[93]. - Cash and cash equivalents increased to CNY 222,077,606.84 from CNY 134,245,173.62, marking a significant rise of approximately 65.4%[91]. - Accounts receivable decreased to CNY 88,890,284.97 from CNY 99,832,727.64, a decline of about 11%[91]. - Inventory increased to CNY 49,505,854.01 from CNY 47,589,573.63, reflecting a growth of approximately 4%[91]. Production and Operations - The production capacity of the company's isothiazolinone-based biocides exceeded 10,000 tons, with plans to surpass 20,000 tons after future projects are completed[25]. - The company is actively advancing projects to increase production capacity for CIT/MIT and BIT series products, aiming for completion by the end of 2018[32]. - The company has maintained stable production without interruptions due to environmental issues, indicating effective operational management[29]. Research and Development - The company has a strong focus on R&D, with expenditures amounting to CNY 3.30 million, a 6.30% increase from the previous year[34]. Environmental Compliance - The company has established a complete environmental management system, conducting annual monitoring of wastewater and air emissions, with real-time data transmission to the environmental protection bureau[68]. - The company’s environmental protection measures are in compliance with the relevant standards, ensuring all emissions are within permissible limits[58]. - The company reported a continuous operation of wastewater treatment facilities with a design capacity of 800 tons/day since 2011[60]. - The company has implemented air pollution control facilities with a design capacity of 2500 cubic meters/hour, operational since 2011[60]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 11,111[78]. - The top ten shareholders held a total of 133,333,334 shares, representing 100% of the total shares[80]. - Dalian Sanxin Investment Co., Ltd. and Dalian Tongyun Investment Co., Ltd. each held 38,666,667 shares, accounting for 29% of the total shares[80]. Risks and Challenges - The company faces risks from intensified domestic market competition, potential leakage of core technology, and environmental protection regulations[42][43]. Corporate Governance - The company experienced a change in its board of directors, with several new appointments made during the reporting period[87]. - The company reported no changes in the controlling shareholder or actual controller during the reporting period[86]. Accounting Policies - The accounting policies and estimates are in accordance with relevant enterprise accounting standards, particularly regarding revenue recognition[122]. - The company does not recognize changes in the fair value of equity instruments in profit or loss[154].

2018 年第一季度报告 公司代码：603360 公司简称：百傲化学 非经常性损益项目和金额 √适用 □不适用 单位：元 币种：人民币 大连百傲化学股份有限公司 2018 年第一季度报告 1 / 18 | 一、 | 重要提示 3 | | --- | --- | | 二、 | 公司基本情况 3 | | 三、 | 重要事项 5 | | 四、 | 附录 8 | 2018 年第一季度报告 一、 重要提示 二、 公司基本情况 2.1 主要财务数据 2018 年第一季度报告 | 家政策规定、按照一定标准定额或 | | | --- | --- | | 定量持续享受的政府补助除外 | | | 除同公司正常经营业务相关的有效 | 512,876.71 | | 套期保值业务外，持有交易性金融 | | | 资产、交易性金融负债产生的公允 | | | 价值变动损益，以及处置交易性金 | | | 融资产、交易性金融负债和可供出 | | | 售金融资产取得的投资收益 | | | 所得税影响额 | -124,219.55 | | 合计 | 703,910.78 | | | 购买银行理财产品收益 | 2.2 截止报告期末的股东总数、前十名股 ...

Financial Performance - The company's operating revenue for 2017 was CNY 410,364,502.50, representing a 5.37% increase compared to CNY 389,433,985.09 in 2016[21] - The net profit attributable to shareholders for 2017 was CNY 100,266,398.87, a 2.03% increase from CNY 98,273,387.87 in 2016[21] - Basic earnings per share decreased by 21.43% to CNY 0.77 in 2017 from CNY 0.98 in 2016[22] - The weighted average return on equity fell by 9.04 percentage points to 14.94% in 2017 compared to 23.98% in 2016[22] - Total revenue for Q4 2017 was CNY 113,966,237.49, with a net profit attributable to shareholders of CNY 18,796,922.05[24] - The total amount of non-recurring gains and losses for 2017 was CNY 8,539,798.19, compared to CNY 5,208,449.76 in 2016[27] - The company achieved operating revenue of CNY 410.36 million, representing a year-on-year growth of 5.37%[44] - The net profit attributable to shareholders was CNY 100.27 million, an increase of 2.03% compared to the previous year[44] Cash Flow and Investments - The net cash flow from operating activities decreased by 36.51% to CNY 76,038,489.56 in 2017 from CNY 119,767,902.83 in 2016[21] - The net cash flow from operating activities was negative CNY 245,565.62 in Q4 2017 due to increased raw material procurement costs[24] - The net cash flow from investing activities showed a drastic increase of 3955.62%, amounting to -$117,559,136.82, attributed to the construction expenditures of fundraising projects[62] - The net cash flow from financing activities increased significantly due to public stock issuance, resulting in a net cash inflow of $51,203,636.53[63] Assets and Liabilities - The total assets at the end of 2017 were CNY 779,330,217.36, a 24.42% increase from CNY 626,367,873.82 at the end of 2016[21] - The net assets attributable to shareholders increased by 49.83% to CNY 687,543,010.40 at the end of 2017 from CNY 458,889,228.75 at the end of 2016[21] - Total current assets increased to CNY 425,178,149.10 from CNY 264,148,380.78, representing a growth of approximately 60.9%[197] - Total liabilities decreased to CNY 92,908,732.45 from CNY 168,276,804.77, a reduction of about 55.2%[199] - Total equity increased to CNY 686,421,484.91 from CNY 458,091,069.05, showing an increase of approximately 49.8%[199] Shareholder Information - The company plans to distribute a cash dividend of CNY 2.5 per 10 shares, totaling CNY 33,335,000.00[5] - The company issued 33.34 million shares in 2017, increasing total shares from 10 million in 2016 to 13.34 million[22] - The total number of ordinary shareholders increased from 11,366 to 12,450 during the reporting period, showing a growth of 9.54%[145] - The top two shareholders, Dalian Sanxin Investment Co., Ltd. and Dalian Tongyun Investment Co., Ltd., each hold 29% of the shares, totaling 38,666,667 shares[147] Research and Development - The company has invested significantly in R&D, with expenditures amounting to CNY 15.17 million, a growth of 8.38% from the previous year[46] - The total R&D expenditure was $15,166,475.66, accounting for 3.70% of total revenue, with 71 R&D personnel representing 14.52% of the total workforce[61] - The company is committed to increasing R&D investment, aiming to raise the proportion of R&D expenses in sales revenue[96] Market and Production - The company specializes in the research, production, and sales of isothiazolinone-based industrial biocides, with a focus on various applications across multiple industries[29] - The market for isothiazolinone biocides is expected to expand further with new applications in aquaculture, agricultural films, and veterinary medicine[33] - The company maintained a high level of production capacity utilization, with no production interruptions due to environmental inspections or safety incidents[39] - The production capacity for isothiazolinone raw materials is expected to exceed 20,000 tons after the completion of future investment projects[34] Risks and Compliance - The company has outlined various risks in its report, which investors should consider[7] - The company faces risks from intensified domestic market competition due to the promotion of environmentally friendly biocides, which may attract new competitors and lead to increased production capacity among existing players[98] - There is a risk of core technology leakage and talent loss, which could adversely affect the company's production and sustainable development, given its leading position in the production of isothiazolinone industrial biocides[98] - The company operates in a heavily polluting industry, facing environmental protection risks that could increase operational costs and impact profitability due to stricter regulations[98] Environmental Management - The company has established various pollution prevention facilities, including wastewater treatment facilities with a design capacity of 800 tons per day, which are in continuous operation[123] - The company has completed environmental impact assessments for several projects, including the CIT/MIT series product reconstruction project, which has been accepted[125] - The company has established a complete environmental management system, including annual monitoring of wastewater and air emissions[132] Corporate Governance - The report includes a standard unqualified audit opinion from Ruihua Certified Public Accountants[4] - The company appointed Ruihua Certified Public Accountants as the auditor for the 2017 fiscal year, with a remuneration of 3.4 million RMB[113] - The company has not faced any risks of suspension or termination of its listing status[114] - The company has established measures to ensure fair pricing in unavoidable related transactions[109]

2017 年第三季度报告 公司代码：603360 公司简称：百傲化学 大连百傲化学股份有限公司 2017 年第三季度报告 1 / 21 | 目录 | | --- | | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 6 | | 四、 | 附录 | 9 | 2017 年第三季度报告 2.1 主要财务数据 单位：元 币种：人民币 本报告期末 上年度末 本报告期末比上年度末增 减(%) 总资产 756,348,161.60 626,367,873.82 20.75 归属于上市公司 股东的净资产 668,726,136.44 458,889,228.75 45.73 年初至报告期末 （1-9 月） 上年初至上年报告期末 （1-9 月） 比上年同期增减(%) 经营活动产生的 现金流量净额 76,284,055.18 81,470,380.61 -6.37 年初至报告期末 （1-9 月） 上年初至上年报告期末 （1-9 月） 比上年同期增减 （%） 营业收入 296,398,265.01 293,977,111.92 0.82 ...

Financial Performance - The company's operating revenue for the first half of 2017 was approximately ¥191 million, representing a 1.99% increase compared to the same period last year[18]. - The net profit attributable to shareholders for the first half of 2017 was approximately ¥54.61 million, a 25.50% increase year-on-year[18]. - The basic earnings per share for the first half of 2017 was ¥0.45, up 2.27% from ¥0.44 in the same period last year[18]. - The net profit after deducting non-recurring gains and losses was approximately ¥51.47 million, reflecting a 24.44% increase compared to the previous year[18]. - The company achieved a main business revenue of 191.02 million RMB, representing a year-on-year growth of 1.99%[30]. - The net profit attributable to shareholders reached 54.61 million RMB, reflecting a significant increase of 25.50% compared to the previous year[30]. - The company reported a significant increase in cash and cash equivalents, reaching RMB 301,736,579.96 as of June 30, 2017, compared to RMB 114,085,492.19 at the beginning of the period, representing a growth of approximately 164%[73]. - The company reported a total comprehensive income of ¥54,592,620.93, up from ¥43,310,077.68 in the previous period[81]. - The total comprehensive income for the period was 60,033,550.00 RMB, reflecting a significant increase compared to the previous period[98]. Assets and Liabilities - The company's total assets increased by 36.74% to approximately ¥856.48 million compared to the end of the previous year[18]. - The company's net assets attributable to shareholders increased by 39.87% to approximately ¥641.86 million compared to the end of the previous year[18]. - Total assets increased to ¥880,759,743.35, up from ¥641,942,887.18, representing a growth of approximately 37.1%[77]. - Current liabilities rose to ¥155,309,244.91 from ¥102,406,464.38, an increase of about 51.7%[77]. - Total liabilities increased to ¥169,689,869.91, compared to ¥119,269,471.23, reflecting a growth of approximately 42.4%[77]. - Total equity reached ¥711,069,873.44, up from ¥522,673,415.95, indicating an increase of around 36.0%[77]. Cash Flow - The net cash flow from operating activities for the first half of 2017 was approximately ¥56.49 million, a 27.73% increase year-on-year[18]. - Cash flow from operating activities increased by 27.73% to 56.49 million RMB, indicating improved sales collection compared to the previous year[33]. - The net cash flow from operating activities generated a net amount of ¥56,492,478.96, an increase of 27.6% from ¥44,229,398.14 in the previous period[86]. - The net cash flow from financing activities was CNY 184,643,636.53, significantly improved from -CNY 23,713,904.83 in the previous period[90]. - The total cash and cash equivalents at the end of the period reached CNY 299,319,209.50, up from CNY 112,524,608.24 at the beginning of the period[90]. Research and Development - Research and development expenses increased by 8.34% to 3.11 million RMB, highlighting the company's commitment to innovation[33]. - The company has obtained 12 invention patents and 8 utility model patents, showcasing its strong R&D and technological innovation capabilities[27]. - The company is focusing on new product development and technological advancements to drive growth in the upcoming periods[98]. Market and Competition - The company specializes in the research, production, and sales of isothiazolinone-based industrial biocides, with a focus on various product series including CIT/MIT, MIT, OIT, DCOIT, and BIT[23]. - The company faces risks from intensified domestic market competition due to increasing environmental requirements and the promotion of isothiazolinone-based biocides, which may attract new competitors and expand existing ones[39]. - The company has established long-term stable partnerships with major chemical giants such as Dow Chemical and Lanxess, ensuring stable foreign sales revenue[31]. Environmental and Safety Risks - The company operates in a heavily polluting industry, with strict adherence to environmental regulations, but potential increases in environmental standards could raise costs and impact profitability[39]. - The company is exposed to safety production risks, including fire hazards during the handling of raw materials, which could lead to significant economic losses if accidents occur[40]. - The company has established strict operational standards to manage environmental impacts from waste generated during production[39]. - The company is committed to increasing environmental investments to comply with legal regulations, which may affect its financial performance[39]. Shareholder and Governance - There are no proposed profit distribution or capital reserve transfer plans for the half-year period[44]. - The company has commitments regarding stock transfer restrictions, including a 36-month lock-up period for major shareholders following the IPO[46]. - Major shareholders are restricted from transferring shares for 12 months post-IPO, with additional conditions if stock prices fall below the issue price[47]. - The company’s strategic investors, including Deep Innovation Investment Management, have established a concerted action relationship, enhancing governance and decision-making[64]. Accounting and Financial Reporting - The accounting policies adhered to the enterprise accounting standards, ensuring transparency and accuracy in financial reporting[106]. - The financial statements are prepared based on the principle of continuous operation, reflecting the company's commitment to long-term growth[104]. - The company recognizes deferred tax assets related to deductible temporary differences if new information indicates that the economic benefits can be realized within 12 months post-acquisition, reducing goodwill accordingly[112]. - The company applies the asset-liability method to recognize deferred tax assets and liabilities based on temporary differences between the book value and tax base of assets and liabilities[167]. Accounts Receivable and Provisions - The total accounts receivable at the end of the period amounted to ¥85,389,406.23, with a total bad debt provision of ¥5,579,833.53, representing a provision rate of approximately 6.53%[185]. - The company recognized a bad debt provision of ¥295,395.87 during the period, while recovering or reversing bad debt provisions amounted to ¥1,670.47[186]. - The actual write-off of accounts receivable during the period was ¥63,600.60, primarily due to long aging and inability to recover[189].

2017 年第一季度报告 公司代码：603360 公司简称：百傲化学 大连百傲化学股份有限公司 2017 年第一季度报告 1 / 18 | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 5 | | 四、 | 附录 | 8 | 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人刘宪武、主管会计工作负责人高兵及会计机构负责人（会计主管人员）刘东光保 证季度报告中财务报表的真实、准确、完整。 1.4 本公司第一季度报告未经审计。 二、 公司基本情况 2017 年第一季度报告 2.1 主要财务数据 单位：元 币种：人民币 | | 本报告期末 | 上年度末 | 本报告期末比上年度末增 | | | --- | --- | --- | --- | --- | | | | | 减(%) | | | 总资产 | 833,934,961.07 | 626,367,8 ...

Financial Performance - The company achieved a consolidated net profit of ¥97,945,999.65 for the year 2016, representing a significant increase of 71.39% compared to the previous year[3]. - Total operating revenue for 2016 was ¥389,433,985.09, reflecting an 18.73% increase from ¥327,991,416.10 in 2015[21]. - The net cash flow from operating activities reached ¥119,767,902.83, which is a 61.77% increase compared to ¥74,035,564.97 in 2015[21]. - The company's total assets as of December 31, 2016, amounted to ¥626,367,873.82, a 14.25% increase from ¥548,252,387.80 at the end of 2015[21]. - The net assets attributable to shareholders of the listed company increased by 27.26% to ¥458,889,228.75 at the end of 2016, up from ¥360,595,037.05 in 2015[21]. - Basic earnings per share increased by 71.93% to CNY 0.98 in 2016 compared to CNY 0.57 in 2015[22]. - The weighted average return on equity rose to 23.98%, an increase of 6.70 percentage points from 17.28% in 2015[22]. - The company reported a net profit attributable to shareholders after deducting non-recurring gains and losses of ¥93,064,938.11, which is a 73.16% increase from the previous year[21]. Dividends and Shareholder Returns - The company plans to distribute a total of ¥133,340,000 in cash dividends to shareholders, amounting to ¥10 per 10 shares (including tax)[3]. - In 2016, the company distributed cash dividends amounting to approximately 133.34 million RMB, representing 135.68% of the net profit attributable to ordinary shareholders[95]. - The company has established a cash dividend policy, committing to distribute at least 20% of the annual distributable profit as cash dividends, provided the net profit is positive[93]. Operational Highlights - The company’s main business focuses on the research, production, and sales of isothiazolinone-based industrial biocides, which are widely used across various industries[31]. - The production model is based on a "sales-driven production" approach, allowing for flexible manufacturing to meet customer-specific requirements[32]. - The company has established long-term stable partnerships with over 500 domestic clients and nearly 100 international clients, including major multinational corporations[36]. - The company has become the largest producer of isothiazolinone biocides in Asia, indicating a strong market position[65]. - The production capacity for isothiazolinone products exceeded 10,000 tons, establishing the company as a leading player in this niche market[35]. Research and Development - Research and development expenses increased by 33.80% to ¥13,791,914.15, highlighting the company's commitment to innovation[43]. - The company has developed 11 invention patents, showcasing its strong technological innovation capabilities[35]. - The company plans to increase R&D investment, aiming to enhance the proportion of R&D expenses in sales revenue over the next three years[85]. - The company will continue to improve its internal talent development and recruitment mechanisms to enhance its R&D capabilities and management strength[86]. Market and Sales Performance - The sales volume of CIT/MIT products increased by 18.60% compared to the previous year, reaching 16,545.58 tons[48]. - The gross profit margin for the South China region was 56.24%, with a revenue increase of 27.01% year-over-year[46]. - The company reported a significant increase in sales from the North America region, with a revenue of approximately 25.64 million, up by 29.03%[46]. - The company’s OIT product sales grew significantly, driven by increased demand from both new and existing customers[47]. Financial Position and Cash Flow - The company's cash and cash equivalents rose to ¥114,085,492.19, representing 18.21% of total assets, a 326% increase from the previous period[58]. - The total cash and cash equivalents at the end of the period increased to CNY 113,983,167.53 from CNY 26,655,372.89, marking a substantial increase of approximately 327.5%[170]. - The net cash flow from investment activities improved by 72.03%, reducing the outflow to ¥2,898,673.93[57]. - The financial expenses decreased significantly by 78.32%, totaling 1.77 million compared to the previous year[53]. Governance and Compliance - The board of directors confirmed the accuracy and completeness of the annual report, ensuring no false records or misleading statements[5]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[5]. - The company has not violated any decision-making procedures for providing guarantees[5]. - The company has not encountered any non-standard audit opinions during the reporting period[101]. - The company has not reported any significant litigation or arbitration matters during the fiscal year[104]. Shareholder Structure and Management - The total number of ordinary shareholders at the end of the reporting period was 7, compared to 17,261 at the end of the previous month[113]. - The company completed its initial public offering of 33.34 million shares, increasing the total share capital from 100 million to 133.34 million shares[111]. - The top ten shareholders include Tongyun Investment and Sanxin Investment, each holding 38,666,667 shares, representing 38.67% of the total shares[115]. - The company has maintained a stable management team with no changes in shareholding among the directors and supervisors[125]. Risks and Challenges - The company recognizes risks such as intensified domestic market competition and potential core technology leakage, which could adversely affect production and sustainable development[89]. - The company is committed to adhering to environmental regulations and has implemented strict operational standards to mitigate environmental risks associated with its production processes[89]. Accounting and Financial Reporting - The company has maintained a stable accounting policy, ensuring compliance with relevant accounting standards[194]. - The company’s financial statements reflect a strong commitment to continuous operation without significant doubts regarding its operational capability[192]. - The company’s accounting currency is Renminbi, ensuring consistency in financial reporting[197].